BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24305560)

  • 1. Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance.
    Osakwe A; Oreagba I; Adewunmi AJ; Adekoya A; Fajolu I
    Int J Risk Saf Med; 2013; 25(4):219-27. PubMed ID: 24305560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
    Awodele O; Adeniran A; Awodele DF
    Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
    Khan Z; Karatas Y; Hamid SM
    PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
    Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
    Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
    Sanghavi DR; Dhande PP; Pandit VA
    Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria.
    Awodele O; Daniel A; Popoola TD; Salami EF
    Int J Risk Saf Med; 2013; 25(4):205-17. PubMed ID: 24305559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perception and practice of malaria prophylaxis in pregnancy among primary health care providers in Ibadan, Nigeria.
    Fawole AO; Onyeaso NC
    West Afr J Med; 2008 Apr; 27(2):92-6. PubMed ID: 19025022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance amongst doctors in private hospitals in Lagos West Senatorial District, Nigeria.
    Awodele O; Akinyede A; Adeyemi OA; Awodele DF
    Int J Risk Saf Med; 2011; 23(4):217-26. PubMed ID: 22156086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking bad news in clinical setting - health professionals' experience and perceived competence in Southwestern Nigeria: a cross sectional study.
    Adebayo PB; Abayomi O; Johnson PO; Oloyede T; Oyelekan AA
    Ann Afr Med; 2013; 12(4):205-11. PubMed ID: 24309408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.